Hudson Bay Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Sell
51,830
-48,170
-48% -$1.37M 0.01% 790
2025
Q4
$2.72M Sell
100,000
-22,500
-18% -$789K 0.02% 648
2025
Q3
$4.92M Sell
122,500
-7,500
-6% -$282K 0.03% 554
2025
Q2
$4.32M Buy
130,000
+19,280
+17% +$584K 0.03% 580
2025
Q1
$3.24M Buy
110,720
+720
+0.7% +$23.9K 0.02% 706
2024
Q4
$3.61M Buy
110,000
+50,000
+83% +$2.35M 0.02% 561
2024
Q3
$2.67M Sell
60,000
-55,000
-48% -$2.5M 0.02% 531
2024
Q2
$4.96M Sell
115,000
-292,500
-72% -$10.6M 0.04% 379
2024
Q1
$11.9M Sell
407,500
-82,500
-17% -$2.21M 0.1% 156
2023
Q4
$10.9M Buy
490,000
+220,000
+81% +$4.93M 0.1% 169
2023
Q3
$6.68M Buy
270,000
+10,000
+4% +$265K 0.06% 225
2023
Q2
$7.36M Sell
260,000
-10,000
-4% -$249K 0.07% 225
2023
Q1
$6.2M Buy
270,000
+60,000
+29% +$1.59M 0.07% 261
2022
Q4
$5.9M Buy
210,000
+30,000
+17% +$845K 0.07% 311
2022
Q3
$5.09M Sell
180,000
-163,500
-48% -$4.39M 0.05% 399
2022
Q2
$7.62M Buy
343,500
+118,500
+53% +$2.68M 0.07% 263
2022
Q1
$6.55M Buy
225,000
+25,000
+13% +$764K 0.09% 268
2021
Q4
$6.57M Buy
200,000
+125,000
+167% +$5.03M 0.07% 251
2021
Q3
$3.46M Buy
75,000
+20,000
+36% +$966K 0.05% 479
2021
Q2
$3.03M Sell
55,000
-30,000
-35% -$1.68M 0.04% 502
2021
Q1
$4.39M Sell
85,000
-95,088
-53% -$4.71M 0.06% 337
2020
Q4
$7.8M Buy
180,088
+42,588
+31% +$1.68M 0.1% 147
2020
Q3
$4.81M Buy
137,500
+102,500
+293% +$4.49M 0.08% 239
2020
Q2
$1.87M Buy
+35,000
New +$1.62M 0.03% 322
2020
Q1
Sell
-70,000
Closed -$3.34M 490
2019
Q4
$3.34M Buy
70,000
+40,000
+133% +$1.51M 0.08% 227
2019
Q3
$972K Buy
+30,000
New +$1.24M 0.03% 322
2019
Q2
Sell
-15,000
Closed -$1.01M 416
2019
Q1
$1.01M Buy
+15,000
New +$874K 0.03% 555

Other funds holding AGIO